TITLE

Oral dexamethasone improved respiratory distress in children < 2 years of age with acute bronchiolitis

AUTHOR(S)
Wyer, Peter C.
PUB. DATE
November 2002
SOURCE
ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses research being done on the effectiveness of oral dexamethasone in improving respiratory distress in children with acute bronchiolitis. Reference to study by S. Schuh and colleagues, published in the January 2002 issue of the 'Journal of Pediatrics'; Information on the study population; Intervention administered to the patients.
ACCESSION #
8718562

 

Related Articles

  • Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis. deAbate, C.A.; Myers, D.; Henry, D.; Upchurch, J.; Lecara, G.; Giguere, G.; Collins, J.J. // Clinical Drug Investigation;1999, Vol. 18 Issue 3, p243 

    Objectives: The clinical and bacteriological efficacies and tolerability of grepafloxacin 400mg once daily for 10 days were compared with clarithromycin 500mg twice daily for 10 days in patients with acute bacterial exacerbations of chronic bronchitis (ABECB). Patients and Study Design: 379...

  • AHRQ: Often-used drugs do not always work.  // Drug Topics;3/17/2003, Vol. 147 Issue 6, p10 

    Focuses on the Agency for Healthcare Research and Quality's (AHRQ) issuance of a report stating that no evidence exists to support the use of commonly prescribed medications like corticosteroids, inhaled epinephrine and nebulized bronchodilators, to treat bronchiolitis. Advice to physicians...

  • Ciprofloxacin is more effective for eradicating bacteria in patients with acute chronic bronchitis.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p30 

    Discusses a study conducted by Sanford Chodosh and colleagues on the efficacy of ciprofloxacin in eradicating bacteria in patients with acute chronic bronchitis, presented at the 1996 meeting of the Infectious Disease Society of America. Comparison of ciprofloxacin's efficacy with that of...

  • Antibiotic for pneumonia, bronchitis.  // Geriatrics;Apr97, Vol. 52 Issue 4, p36 

    Discusses information about Sparfloxacin, a broad-spectrum antibiotic indicated for the treatment of pneumonia and bronchitis caused by designated susceptible microorganisms. How sparfloxacin is similar to erythromycin, cefaclor and ofloxacin; Recommended dosage for taking sparfloxacin;...

  • Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis. deAbate, C.A.; Myers, D.; Henry, D.; Upchurch, J.; Lecara, G.; Giguere, G.; Collins, J.J. // Clinical Drug Investigation;1999, Vol. 17 Issue 1, p21 

    Objectives: The clinical and bacteriological efficacies and tolerability of grepafloxacin 400mg once daily for 10 days were compared with clarithromycin 500mg twice daily for 10 days in patients with acute bacterial exacerbations of chronic bronchitis (ABECB). Patients and Study Design: 379...

  • Ribavirin and acute bronchiolitis in infancy. Milner, A.D. // BMJ: British Medical Journal (International Edition);10/22/88, Vol. 297 Issue 6655, p998 

    Examines the efficacy of ribavirin as a treatment for acute bronchiolitis in infancy. Adverse effects of ribavirin; Implications for the administration of ribavirin to previously healthy babies with bronchiolitis; Prevalence and mortality of acute bronchiolitis in infancy.

  • P & T PORTFOLIO.  // Drug Topics;6/16/2003, Vol. 147 Issue 12, DRUG TOPICS... p21 

    Features the drug gemifloxacin, used in the treatment of acute bacterial exacerbation of chronic bronchitis in the U.S. Dosage; Occurrence of side effects; Efficacy of the drug.

  • Ciprofloxacin, clarithromycin are comparable for bronchitis attacks. Anzueto, Antonio // Modern Medicine;Dec97, Vol. 65 Issue 12, p43 

    Compares the efficacy of quinolone ciprofloxacin and macrolide clarithromycin in the treatment of severe exacerbations of chronic bronchitis. Higher improvement rate on patients under ciprofloxacin treatment; Increase on the eradication of pathogens responsible for infection on ciprofloxacin...

  • Should bronchodilators be combined in chronic bronchitis and emphysema. Flenley, D.C. // British Medical Journal (Clinical Research Edition);11/7/1987, Vol. 295 Issue 6607, p1160 

    Evaluates the effectiveness of the combination of oral theophyllines with inhaled agonists in chronic bronchitis and emphysema. Benefits of the combination therapy; Improvement of diaphragmatic contractility; Mechanism of action of the therapy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics